Inveready achieves first close of Biotech IV at €45 million with core investors
The venture capital manager highlights that its first specialized fund returned five times the investment.
April 27, 2023
The venture capital manager highlights that its first specialized fund returned five times the investment, while the second is expected to achieve four times.
Venture capital manager Inveready has completed the first close of its new biotechnology fund within five months and solely with investors who had previously entered into one of its vehicles. Inveready Biotech IV has reached a volume of €45 million and will now enter the marketing phase to reach and possibly exceed its target of €50 million.
27/04/2023
Inveready achieves first close of Biotech IV at €45 million with core investors
The venture capital manager highlights that its first specialized fund returned five times the investment.